Symptom Status and Quality of Life Following Prostatectomy

JAMA: The Journal of the American Medical Association

Volumn 259, Issue 20, 1988, Pages 3018-3022

  Fowler, Floyd J ^a   Wennberg, John E ^b   Timothy, Robert P ^c   Barry, Michael J ^d   Mulley, Albert G ^d   Hanley, Daniel ^c  

^a UNIVERSITY OF MASSACHUSETTS BOSTON   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c Maine Medical Assessment Program ^*  (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DECISION MAKING; HUMAN; MALE; PRIORITY JOURNAL; PROSTATECTOMY; PROSTATISM;

AGED; AGED, 80 AND OVER; HUMAN; MALE; PATIENT PARTICIPATION; PROSTATECTOMY; PROSTATIC HYPERPLASIA; QUALITY OF LIFE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023883564     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1988.03720200040030     Document Type: Article

References (22)

1. Barnes BA, O’Brien E, Comstock C, et al.: Report on variation in rates of utilization of surgical services in the Commonwealth of Massachusetts. JAMA 1985;254:371-379.
2. Wennberg JE, Gittelsohn A: Health care delivery in Maine: I. Patterns of use of common surgical procedures. J Maine Med Assoc 1975;66:123-130, 149.
3. McPherson K, Wennberg JE, Hovind OB, et al.: Small-area variation in the use of common surgical procedures: An international comparison of New England, England, and Norway. N Engl J Med 1982;307:1310-1314.
4. Wennberg J, Gittelsohn A: Variations in medical care among small areas. Sci Am 1982;246:120-134.
5. Wennberg JE, Bunker JP, Barnes B: The need for assessing the outcome of common medical practices. Annu Rev Public Health 1980;1:277-295.
6. Confronting Regional Variations: The Maine Approach. Chicago, Dept of Health Care Review, Division of Health Policy and Program Evaluation, American Medical Association, 1986.
7. McAfee RE: The hospital ’surgical signature’: A quality-assessment tool. JAMA 1987;257:972.
8. Wennberg JE, Roos N, Sola L, et al.: Use of claims data systems to evaluate health care outcomes: Mortality and reoperation following prostatectomy. JAMA 1987;257:933-936.
9. Barry MJ, Mulley AG, Fowler FJ, et al.: Watchful waiting vs immediate transurethral resection for symptomatic prostatism: The importance of patients’preferences. JAMA 1988;259:3010-3017.
10. Wennberg JE, Mulley AG, Hanley D, et al.: An evaluation of prostatectomy for benign urinary tract obstruction: Geographic variations and the assessment of medical care outcomes. JAMA 1988;259:3027-3030.
11. Cronbach LJ: Coefficient alpha and the internal structure of tests. Psychometrika 1951;16:297.
12. Helmstadter GD: Principles of Psychological Measurement. New York, Appleton-Century-Crofts, 1964.
13. Ware J, Davies A: Scoring the Short-Form Mental Health Inventory (MHI-5). Santa Monica, Calif, The Rand Corporation, 1983.
14. Veit CT, Ware JE: The structure of psychological distress and well-being in general populations. J Consult Clin Psychol 1983;51:730.
15. Brook RH, Ware JE, Davies-Avery A, et al.: Conceptualization and Measurement of Health for Adults in the Health Insurance Study: Vol 8, Overview. Santa Monica, Calif, The Rand Corporation, 1979.
16. Birkoff JD, Weiderhorn AR, Hamilton MC, et al.: Natural history of benign prostatic hypertrophy and acute urinary retention. Urology 1976;7:48-52.
17. Ball AJ, Feneley RC, Abrams PH: The natural history of untreated ’prostatism.’ Br J Urol 1981;53:613-616.
18. Craigen AA, Hickling JB, Saunders CRG, et al.: Natural history of prostatic obstruction. J R Coll Gen Pract 1969;18:226-232.
19. Resnick M, Jackson JE, Watts LE, et al.: Assessment of the antihypercholesterolemic drug, probucol, in benign prostatic hyperplasia. J Urol 1983;129:206-209.
20. Hedlund H, Anderson KE, Ek A: Effects of prazocin in patients with benign prostatic obstruction. J Urol 1983;130:275-278.
21. Castro JE, Griffiths JH, Edwards DE: A double-blind, controlled clinical trial of spironolactone for benign prostatic hypertrophy. Br J Surg 1971;58:485-489.
22. Geller J, Nelson CG, Albert JD, et al.: Effect of megestrol on uroflow rates in patients with benign prostatic hypertrophy. Urology 1979;14:467-474.